Eli Lilly
Lilly opens fourth US Gateway Labs site
September 26, 2025Research and Development Eli Lilly, Local Investment, biotech, life sciences
Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, expanding its network of shared …
Lilly’s drug for early Alzheimer’s shows promising results
August 6, 2025Medical Communications, Research and Development Alzheimer's, Eli Lilly, Neurology, dementia
Eli Lilly (Lilly) has announced positive new data from the long-term extension of its phase 3 study, showing that Kisunla …
Roche receives CE Mark for blood test to help rule out Alzheimer’s
July 30, 2025Research and Development Alzheimer's disease, CE Mark approval, Eli Lilly, Neurology, Roche
Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in vitro diagnostic regulation-certified blood-based diagnostic …
Eli Lilly appoints new chief AI officer
October 17, 2024AI and ML, Corporate, Eli Lilly
Eli Lilly has announced the appointment of Thomas J Fuchs as its first chief artificial intelligence (AI) officer. Fuchs’ appointment …
Eli Lilly announces two senior hires in Public Affairs and Communications team
September 27, 2024Corporate, Eli Lilly
Pharmaceutical company Eli Lilly has announced the appointment of two senior positions in its Public Affairs and Communications team. James …
Eli Lilly’s Kisunla approved by FDA for Alzheimer’s treatment
July 3, 2024Medical Communications Alzheimer's, Eli Lilly, Kisunla, Neurology
Eli Lilly has announced that the US Food and Drug Administration (FDA) has approved Kisunla (donanemab-azbt, 350mg/20ml once-monthly injection for …
Eli Lilly shares results for tirzepatide for MASH resolution
June 10, 2024Research and Development Eli Lilly, Hepatology, MASH, clinical trial, liver
Eli Lilly has announced results from the phase 2 SYNERGY-NASH study which assessed 190 patients, with or without type 2 …
Eli Lilly and UNICEF expand support for young people at risk of noncommunicable diseases
May 30, 2024Medical Communications Eli Lilly, Pharmacy, Unicef, investment, noncommunicable diseases
Eli Lilly has announced that it will donate $6.5m to the United States Fund for UNICEF in order to expand …
Eli Lilly increases manufacturing investment to $9bn at new Indiana site
May 28, 2024Manufacturing and Production Diabetes, Eli Lilly, Indiana, investment, manufacturing
Eli Lilly has announced that it has more than doubled its investment at its Lebanon, Indiana, US manufacturing site with …
Eli Lilly shares positive results from phase 3 VIVID-1 trial of Crohn’s disease treatment
May 22, 2024Medical Communications Crohn’s disease, Eli Lilly, Endocrinology, clinical trial, mirikizumab
Eli Lilly has announced results from its pivotal phase 3 VIVID-1 study, which assessed patients with moderately to severely active …
Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals
April 24, 2024Manufacturing and Production Eli Lilly, Nexus Pharmaceuticals, Pharmacy, acquisition, facility
Eli Lilly and Nexus Pharmaceuticals have announced that they have entered into a definitive agreement for Eli Lilly to acquire …
Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity
April 18, 2024Research and Development Ear Nose & throat, Eli Lilly, clinical trial, sleep apnoea, tirzepatide
Eli Lilly has announced positive topline results from its SURMOUNT-OSA phase 3 trials which demonstrated that tizepatide injection (10mg or …
Zuellig Pharma acquires Cialis and Alimta from Eli Lilly in certain ASEAN markets
February 5, 2024Business Services Cialis, Eli Lilly, Pharmacy, Zuellig Pharma, acquisition
Zuellig Pharma has announced that it has completed the acquisition of two brands Cialis (Tadalafil) and Alita (Pemetrexed) from Eli …
Isomorphic Labs to collaborate with Eli Lilly
January 11, 2024Research and Development AI, Eli Lilly, Isomorphic Labs, Pharmacy, drug discovery
Isomorphic Labs has announced that it has entered into a strategic research collaboration with Eli Lilly and Company, marking the …
Eli Lilly launches digital healthcare process
January 5, 2024Medical Communications Diabetes, Eli Lilly, Obesity, diabetes, obesity
Eli Lilly has announced its new digital healthcare experience, LillyDirect, which will benefit patients in the US with obesity, migraine …
